Particle.news

Download on the App Store

Study Finds Mamba Venoms Trigger Two Types of Paralysis, Exposing a Critical Antivenom Gap

The findings explain post-treatment relapses by revealing a presynaptic component current products miss.

Overview

  • University of Queensland researchers tested venoms from all four mamba species and three African antivenoms, finding the presynaptic, spastic-paralysis component remains unneutralised.
  • Black, western green and Jameson’s mambas were shown to cause both postsynaptic flaccid paralysis and presynaptic spastic paralysis, clarifying why some patients worsen after initial improvement.
  • Mechanistic analyses indicate postsynaptic toxins block nicotinic acetylcholine receptors while presynaptic toxins boost acetylcholine release, leading to muscle spasms and respiratory compromise.
  • Venom function varied by geography, notably between Kenyan and South African black mambas, complicating region-specific effectiveness of existing polyvalent antivenoms.
  • Researchers urge enriched or redesigned antivenoms and exploration of monoclonal antibody approaches, warning that limited ventilator access and funding constraints hamper care in high-burden regions.